John T. Potts Jr serves as Executive at CELL GENESYS INC, where they oversee executive responsibilities. Since joining the company, John T. Potts Jr has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 9, 2017 involved receiving (via award) 23,753 shares valued at $0.
John T. Potts Jr currently holds 159,253 shares of CELL GENESYS INC (CEGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John T. Potts Jr has been a net neutral trader of CEGE stock. They have purchased $0 and sold $0 worth of shares.
John T. Potts Jr's most recent insider trade was on Jun 9, 2017, when they sold 23,753 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 2, 2016 | NK | $29.8K | Option Exercise | 135,500 | $0.22 | Discretionary |
| Feb 10, 2016 | NK | $22.0K | Option Exercise | 100,000 | $0.22 | Discretionary |
| Oct 14, 2009 | CEGE | $0 | Disposition | 30,536 | $N/A | Discretionary |
| Oct 14, 2009 | BPAX | $0 | Award | 5,581 | $N/A | Discretionary |
| Jun 30, 2008 | CEGE | $0 | Award | 4,000 | $N/A | Discretionary |
| Jun 29, 2007 | CEGE | $0 | Award | 4,000 | $N/A | Discretionary |